These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 27662557)

  • 1. Inequalities by educational level in response to combination antiretroviral treatment and survival in HIV-positive men and women in Europe.
    Socio-economic Inequalities and HIV Working Group for Collaboration of Observational HIV Epidemiological Research in Europe (COHERE) in Euro-Coord
    AIDS; 2017 Jan; 31(2):253-262. PubMed ID: 27662557
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Delayed HIV diagnosis and initiation of antiretroviral therapy: inequalities by educational level, COHERE in EuroCoord.
    ; Lodi S; Dray-Spira R; Touloumi G; Braun D; Teira R; D'Arminio Monforte A; Gallois A; Zangerle R; Spire B; Dabis F; Stähelin C; Termote M; Kirk O; Chêne G; Egger M; del Amo J
    AIDS; 2014 Sep; 28(15):2297-306. PubMed ID: 25313585
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunological and virological response to antiretroviral treatment in migrant and native men and women in Western Europe; is benefit equal for all?
    Migrant Health Working Group for the Collaboration of Observational HIV Epidemiological Research in Europe (COHERE) in EuroCoord
    HIV Med; 2018 Jan; 19(1):42-48. PubMed ID: 28741837
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Educational gradient in HIV diagnosis delay, mortality, antiretroviral treatment initiation and response in a country with universal health care.
    Sobrino-Vegas P; Rodríguez-Urrego J; Berenguer J; Caro-Murillo AM; Blanco JR; Viciana P; Moreno S; Bernardino I; del Amo J;
    Antivir Ther; 2012; 17(1):1-8. PubMed ID: 22267463
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term trends in mortality and AIDS-defining events after combination ART initiation among children and adolescents with perinatal HIV infection in 17 middle- and high-income countries in Europe and Thailand: A cohort study.
    ; Judd A; Chappell E; Turkova A; Le Coeur S; Noguera-Julian A; Goetghebuer T; Doerholt K; Galli L; Pajkrt D; Marques L; Collins IJ; Gibb DM; González Tome MI; Navarro M; Warszawski J; Königs C; Spoulou V; Prata F; Chiappini E; Naver L; Giaquinto C; Thorne C; Marczynska M; Okhonskaia L; Posfay-Barbe K; Ounchanum P; Techakunakorn P; Kiseleva G; Malyuta R; Volokha A; Ene L; Goodall R
    PLoS Med; 2018 Jan; 15(1):e1002491. PubMed ID: 29381702
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Timing of combined antiretroviral treatment initiation in male and female migrants living with HIV in Western Europe.
    Migrant Health Working Group for the Collaboration of Observational HIV Epidemiological Research in Europe (COHERE) in EuroCoord
    AIDS; 2017 Mar; 31(6):835-846. PubMed ID: 28272136
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sex differences in overall and cause-specific mortality among HIV-infected adults on antiretroviral therapy in Europe, Canada and the US.
    Antiretroviral Therapy Cohort Collaboration (ART-CC)
    Antivir Ther; 2015; 20(1):21-8. PubMed ID: 24675571
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pretreatment CD4 cell slope and progression to AIDS or death in HIV-infected patients initiating antiretroviral therapy--the CASCADE collaboration: a collaboration of 23 cohort studies.
    Wolbers M; Babiker A; Sabin C; Young J; Dorrucci M; Chêne G; Mussini C; Porter K; Bucher HC;
    PLoS Med; 2010 Feb; 7(2):e1000239. PubMed ID: 20186270
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reference curves for CD4 T-cell count response to combination antiretroviral therapy in HIV-1-infected treatment-naïve patients.
    Bouteloup V; Sabin C; Mocroft A; Gras L; Pantazis N; Le Moing V; d'Arminio Monforte A; Mary-Krause M; Roca B; Miro JM; Battegay M; Brockmeyer N; Berenguer J; Morlat P; Obel N; De Wit S; Fätkenheuer G; Zangerle R; Ghosn J; Pérez-Hoyos S; Campbell M; Prins M; Chêne G; Meyer L; Dorrucci M; Torti C; Thiébaut R;
    HIV Med; 2017 Jan; 18(1):33-44. PubMed ID: 27625009
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changing Incidence and Risk Factors for Kaposi Sarcoma by Time Since Starting Antiretroviral Therapy: Collaborative Analysis of 21 European Cohort Studies.
    Cancer Project Working Group for the Collaboration of Observational HIV Epidemiological Research Europe (COHERE) study in EuroCoord
    Clin Infect Dis; 2016 Nov; 63(10):1373-1379. PubMed ID: 27535953
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Life expectancy of persons receiving combination antiretroviral therapy in low-income countries: a cohort analysis from Uganda.
    Mills EJ; Bakanda C; Birungi J; Chan K; Ford N; Cooper CL; Nachega JB; Dybul M; Hogg RS
    Ann Intern Med; 2011 Aug; 155(4):209-16. PubMed ID: 21768555
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Opportunistic infections and AIDS malignancies early after initiating combination antiretroviral therapy in high-income countries.
    ; Lodi S; del Amo J; Moreno S; Bucher HC; Furrer H; Logan R; Sterne J; Pérez-Hoyos S; Jarrín I; Phillips A; Olson A; van Sighem A; Reiss P; Sabin C; Jose S; Justice A; Goulet J; Miró JM; Ferrer E; Meyer L; Seng R; Vourli G; Antoniadou A; Dabis F; Vandenhede MA; Costagliola D; Abgrall S; Hernán MA
    AIDS; 2014 Oct; 28(16):2461-73. PubMed ID: 25265230
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does region of origin influence the timing and outcome of first-line antiretroviral therapy in France?
    Gatey C; Brun A; Hamet G; Diamantis S; Sellier P; Bouchaud O; Garrait V; Rozenbaum W; Molina JM; Abgrall S;
    HIV Med; 2019 Feb; 20(2):175-181. PubMed ID: 30506853
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Global temporal changes in the proportion of children with advanced disease at the start of combination antiretroviral therapy in an era of changing criteria for treatment initiation.
    Panayidou K; Davies MA; Anderegg N; Egger M;
    J Int AIDS Soc; 2018 Nov; 21(11):e25200. PubMed ID: 30614622
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of antiretroviral therapy on tuberculosis incidence among HIV-positive patients in high-income countries.
    del Amo J; Moreno S; Bucher HC; Furrer H; Logan R; Sterne J; Pérez-Hoyos S; Jarrín I; Phillips A; Lodi S; van Sighem A; de Wolf W; Sabin C; Bansi L; Justice A; Goulet J; Miró JM; Ferrer E; Meyer L; Seng R; Toulomi G; Gargalianos P; Costagliola D; Abgrall S; Hernán MA;
    Clin Infect Dis; 2012 May; 54(9):1364-72. PubMed ID: 22460971
    [TBL] [Abstract][Full Text] [Related]  

  • 16. When to initiate combined antiretroviral therapy to reduce mortality and AIDS-defining illness in HIV-infected persons in developed countries: an observational study.
    ; Cain LE; Logan R; Robins JM; Sterne JA; Sabin C; Bansi L; Justice A; Goulet J; van Sighem A; de Wolf F; Bucher HC; von Wyl V; Esteve A; Casabona J; del Amo J; Moreno S; Seng R; Meyer L; Perez-Hoyos S; Muga R; Lodi S; Lanoy E; Costagliola D; Hernan MA
    Ann Intern Med; 2011 Apr; 154(8):509-15. PubMed ID: 21502648
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The influence of age-associated comorbidities on responses to combination antiretroviral therapy in older people living with HIV.
    Ahn MY; Jiamsakul A; Khusuwan S; Khol V; Pham TT; Chaiwarith R; Avihingsanon A; Kumarasamy N; Wong WW; Kiertiburanakul S; Pujari S; Nguyen KV; Lee MP; Kamarulzaman A; Zhang F; Ditangco R; Merati TP; Yunihastuti E; Ng OT; Sim BLH; Tanuma J; Ratanasuwan W; Ross J; Choi JY;
    J Int AIDS Soc; 2019 Feb; 22(2):e25228. PubMed ID: 30803162
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Survival outcomes and effect of early vs. deferred cART among HIV-infected patients diagnosed at the time of an AIDS-defining event: a cohort analysis.
    Miro JM; Manzardo C; Mussini C; Johnson M; d'Arminio Monforte A; Antinori A; Gill MJ; Sighinolfi L; Uberti-Foppa C; Borghi V; Sabin C;
    PLoS One; 2011; 6(10):e26009. PubMed ID: 22043301
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Survival of HIV-infected adolescents on antiretroviral therapy in Uganda: findings from a nationally representative cohort in Uganda.
    Bakanda C; Birungi J; Mwesigwa R; Nachega JB; Chan K; Palmer A; Ford N; Mills EJ
    PLoS One; 2011 Apr; 6(4):e19261. PubMed ID: 21559441
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of geographic origin, sex, and HIV transmission group on the outcome of first-line combined antiretroviral therapy in France.
    de Monteynard LA; Matheron S; Gilquin J; Pavie J; de Truchis P; Grabar S; Launay O; Meynard JL; Khuong-Josses MA; Rey D; Simon A; Mahamat A; Dray-Spira R; Costagliola D; Abgrall S;
    AIDS; 2016 Sep; 30(14):2235-46. PubMed ID: 27428741
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.